DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Umbricht D, Lentz E, Santarelli L et al.
A post-hoc analysis of the negative symptom factor score in a proof-of-concept study with the Gylcine Reuptake Inhibitor (GRI), Bitopertin, in schizophrenia.
European Neuropsychopharmacology 2012;
22: S311
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.